Gossamer Bio: Funding, Investors & Team (Oct 2026)
Gossamer Bio is a San Diego-put together organization centered with respect to the revelation and improvement of novel and separated remedial items, to address high neglected needs among different designated patient populaces. Established by the previous Receptos chief group, Gossamer Bio's system will be to use a resource rich in-permitting climate, with an emphasis on areas of high neglected need, using a group with major areas of strength for a record of execution in immunology, irritation, fibrosis and oncology.
Gossamer Bio has raised $120M across 1 funding round on record, the most recent a Post-IPO Equity of $120M announced in Jul 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gossamer Bio Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Gossamer Bio Funding Rounds
Gossamer Bio Founders and Leadership Team
No contact details are on record for this team yet.
Gossamer Bio Funding Compared to Other Biotechnology Startups
Gossamer Bio's latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gossamer Bio in Biotechnology and San Diego
Companies Similar to Gossamer Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Gossamer Bio Funding FAQs
What does Gossamer Bio do?
Gossamer Bio is a San Diego-put together organization centered with respect to the revelation and improvement of novel and separated remedial items, to address high neglected needs among different designated patient populaces. Established by the previous Receptos chief group, Gossamer Bio's system will be to use a resource rich in-permitting climate, with an emphasis on areas of high neglected need, using a group with major areas of strength for a record of execution in immunology, irritation, fibrosis and oncology.
How much funding has Gossamer Bio raised?
Gossamer Bio has raised $120M across 1 round on record. The most recent is a Post-IPO Equity of $120M announced in Jul 2022.
When did Gossamer Bio last raise funding?
Gossamer Bio's most recent funding round on record is a Post-IPO Equity of $120M, announced in Jul 2022.
Who is the CEO of Gossamer Bio?
Sheila Gujrathi is listed as CEO at Gossamer Bio.
Where is Gossamer Bio headquartered?
Gossamer Bio is based in San Diego, California, United States.
How many employees does Gossamer Bio have?
Gossamer Bio is in the 101-250 employee band.
How does Gossamer Bio's funding compare to other Biotechnology startups?
Gossamer Bio's latest round of $120M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gossamer Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gossamer Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.